Cargando…
French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long
BACKGROUND: Hepatitis C virus (HCV) elimination by 2030, as targeted by the World Health Organization (WHO), requires that 90% of people with chronic infection be diagnosed and 80% treated. We estimated the cascade of care (CoC) for chronic HCV infection in mainland France in 2011 and 2016, before a...
Autores principales: | Brouard, Cécile, Pillonel, Josiane, Boussac, Marjorie, de Lédinghen, Victor, Rachas, Antoine, Silvain, Christine, Lydié, Nathalie, Chevaliez, Stéphane, Pioche, Corinne, Durand, Julien, Lot, Florence, Delarocque-Astagneau, Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559725/ https://www.ncbi.nlm.nih.gov/pubmed/33059617 http://dx.doi.org/10.1186/s12879-020-05478-6 |
Ejemplares similares
-
Rapid and large-scale implementation of HCV treatment advances in France, 2007–2015
por: Brouard, Cécile, et al.
Publicado: (2017) -
HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy
por: Brouard, Cécile, et al.
Publicado: (2019) -
The Undiagnosed Chronically-Infected HCV Population in France. Implications for Expanded Testing Recommendations in 2014
por: Brouard, Cécile, et al.
Publicado: (2015) -
Innovative Approach for Enhancing Testing of HIV, Hepatitis B, and Hepatitis C in the General Population: Protocol for an Acceptability and Feasibility Study (BaroTest 2016)
por: Lydié, Nathalie, et al.
Publicado: (2018) -
Clinical and virological features of chronic hepatitis B in the French national surveillance program, 2008–2012: A cross-sectional study
por: Chevaliez, Stéphane, et al.
Publicado: (2022)